The purpose of this study is to determined if combination therapy radiation is more effective than single agent therapy with radiation. Patients must be diagnosed with a Methylated MGMT promoter Gliblastoma.
Contact phone
(517) 364-2835
Contact email
cancerclinicaltrials@sparrow.org
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Gliblastoma
Webform